Virginia Retirement Systems’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-13,550
Closed -$443K – 1376
2026
Q2
$443K Buy
13,550
+2,900
+27% +$93.1K ﹤0.01% 1001
2026
Q1
$347K Buy
10,650
+4,100
+63% +$134K ﹤0.01% 831
2025
Q4
$208K Buy
+6,550
New +$197K ﹤0.01% 912
2023
Q3
$58.7K Sell
14,900
-700
-4% -$4.6K ﹤0.01% 932
2023
Q2
$166K Sell
15,600
-300
-2% -$3.19K ﹤0.01% 933
2023
Q1
$132K Sell
15,900
-1,200
-7% -$10.8K ﹤0.01% 989
2022
Q4
$158K Buy
17,100
+1,900
+13% +$19.8K ﹤0.01% 1074
2022
Q3
$195K Buy
+15,200
New +$242K ﹤0.01% 1062
2022
Q1
$322K Buy
+15,300
New +$306K ﹤0.01% 959

Other funds holding STOK

Virginia Retirement Systems's STOK Position: Q3 2026 in Review

Virginia Retirement Systems sold out of Stoke Therapeutics (STOK) in Q3 2026, closing a stake of 13,550 shares — an estimated $443K sold.

Virginia Retirement Systems first reported a position in STOK in Q1 2022 and held it in 9 quarters. The position peaked at $443K in Q2 2026. 184 funds tracked by Wall St. Rank hold STOK as of Q3 2026.

  • Virginia Retirement Systems reported no remaining Stoke Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Virginia Retirement Systems sold 13,550 Stoke Therapeutics shares in Q3 2026, an estimated $443K.
  • Virginia Retirement Systems first reported a position in Stoke Therapeutics in Q1 2022 and held it in 9 quarters.
  • Virginia Retirement Systems's Stoke Therapeutics position peaked at $443K in Q2 2026.
  • 184 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q3 2026.

Based on Virginia Retirement Systems's 13F filing for Q3 2026, filed 28 Oct 2026.